Debate
First stage production of Dayglo, Autumn 2011. Photographs by Robert Workman.
'Dayglo' has been developed in partnership with The Association of Medical Research Charities (AMRC) and the University of Ulster. The production will explore the social, moral, scientific and political questions raised by advances in pharmacogenetics, defined as the study of how genetic variation affects our response to medicines
The process of creating 'Dayglo' relied upon the input of various experts from an advisory group including Kimberly Jamie, Maggie Alexander, Professor Katherine Payne, Dr Olivier Harari, Professor Munir Pirmohamed, Professor Valerie McKelvey-Martin, and Dr Sophie Petit-Zeman,
On May 18th 2011, the advisory group, along with young people from local schools, other stakeholders and playwright Abi Bown, participated in an interactive workshop exploring perceptions around the issues the project proposes to explore. Several Advisory Group members gave presentations, expressing their point of view.
Kimberly Jamie,ESRC/Pharmacy Practice Research Trust PhD student, University of York
Watch Kimberly Jamie's presentation
Maggie Alexander, Director of Policy, Education and Influencing, Breakthrough Breast Cancer
Watch Maggie Alexander's presentation
Professor Katherine Payne, Professor of Health Economics, Health Sciences – Methodology School of Community Based Medicine, The University of Manchester
Watch Professor Katherine Payne's presentation
Professor Munir Pirmohamed,NHS Chair of Pharmacogenetics, University of Liverpool
Watch Professor Munir Pirmohamed's presentation
Professor Valerie McKelvey-Martin, Head of Engagement and Professor of Molecular Biosciences, Department of Pharmacy and Pharmaceutical Sciences, University of Ulster, Coleraine (UUC)
Watch Professor Valerie McKelvey-Martin's presentation
Dr. Sophie Petit-Zeman, Adviser, Patient Involvement & Engagement, Association of Medical Research Charities (AMRC)
Find out more about Dr Sophie Petit-Zeman
Dr Olivier Harari,Clinical Science Leader, Roche Products Ltd
Find out more about Dr Olivier Harai
Following the workshop, Abi Bown then submitted two synopses to Y Touring and the Advisory Group and 'Dayglo' was the synopsis chosen to be commissioned.
The process of creating 'Dayglo' relied upon the input of various experts from an advisory group including Kimberly Jamie, Maggie Alexander, Professor Katherine Payne, Dr Olivier Harari, Professor Munir Pirmohamed, Professor Valerie McKelvey-Martin, and Dr Sophie Petit-Zeman,
On May 18th 2011, the advisory group, along with young people from local schools, other stakeholders and playwright Abi Bown, participated in an interactive workshop exploring perceptions around the issues the project proposes to explore. Several Advisory Group members gave presentations, expressing their point of view.
Kimberly Jamie,ESRC/Pharmacy Practice Research Trust PhD student, University of York
Watch Kimberly Jamie's presentation
Maggie Alexander, Director of Policy, Education and Influencing, Breakthrough Breast Cancer
Watch Maggie Alexander's presentation
Professor Katherine Payne, Professor of Health Economics, Health Sciences – Methodology School of Community Based Medicine, The University of Manchester
Watch Professor Katherine Payne's presentation
Professor Munir Pirmohamed,NHS Chair of Pharmacogenetics, University of Liverpool
Watch Professor Munir Pirmohamed's presentation
Professor Valerie McKelvey-Martin, Head of Engagement and Professor of Molecular Biosciences, Department of Pharmacy and Pharmaceutical Sciences, University of Ulster, Coleraine (UUC)
Watch Professor Valerie McKelvey-Martin's presentation
Dr. Sophie Petit-Zeman, Adviser, Patient Involvement & Engagement, Association of Medical Research Charities (AMRC)
Find out more about Dr Sophie Petit-Zeman
Dr Olivier Harari,Clinical Science Leader, Roche Products Ltd
Find out more about Dr Olivier Harai
Following the workshop, Abi Bown then submitted two synopses to Y Touring and the Advisory Group and 'Dayglo' was the synopsis chosen to be commissioned.
